Latest Shareholder Approvals News

Pure Foods Tasmania has secured a $400,000 investment from entrepreneurs Jon Kontopos and Matthew Abrahams as part of a broader $750,000 capital raising effort, reinforcing confidence in the company’s turnaround plan ahead of its upcoming shareholder vote.

Nine Entertainment Co. Holdings Limited reported a modest dip in FY25 net profit to $133.3 million amid rising costs, while announcing a substantial special dividend tied to the imminent sale of its Domain stake.

Lovisa Holdings Limited reported a 14.2% revenue increase to A$798.1 million for FY25, driven by a net addition of 131 stores globally. Profit after tax rose 4.8% to A$86.3 million, while the company declared a final unfranked dividend of 27 cents per share.

RPMGlobal completes its transition to a pure-play software company, reporting robust FY25 results driven by subscription revenue growth and a $63.6 million Advisory divestment. The company projects significant margin expansion and revenue growth in FY26 backed by a $200 million contract backlog.

Arafura Rare Earths has successfully completed the first tranche of its A$80 million capital raising, issuing 369.6 million new shares and securing A$70.2 million before costs. The remaining tranche awaits shareholder approval.

Fluence Corporation has agreed with its revolving lenders, who are also board members, to convert $1.8 million of accrued interest into shares, pending shareholder approval. This move aims to preserve cash and enhance operational flexibility as the company pursues growth.

Decidr AI Industries has locked in a $3.9 million underwriting agreement with Morgans Corporate Limited to back the exercise of listed options expiring this month, providing crucial funding ahead of its DecidrOS Beta release.

Kip McGrath Education Centres announces a one-year on-market share buy-back of up to 10% of its shares, aiming to enhance shareholder value amid strong cash reserves and profitability forecasts.

Peninsula Energy has successfully completed the first tranche of a fully underwritten A$69.9 million equity raise, securing strong institutional support including cornerstone investors Tees River and Davidson Kempner. The company now opens its retail entitlement offer to shareholders, aiming to fund the ramp-up of uranium production at its Lance Project in Wyoming.

Amplia Therapeutics has successfully raised A$2.65 million through its Share Purchase Plan, exceeding expectations and bolstering funding for pivotal clinical trials of its lead drug narmafotinib.

Ainsworth Game Technology has terminated its proposed scheme of arrangement with Novomatic due to insufficient shareholder support, yet the board still recommends accepting Novomatic’s unconditional $1 per share takeover bid.

Fluence Corporation has announced Ben Fash as its new CEO and Managing Director, succeeding Tom Pokorsky who will retire after a distinguished career. The transition marks a strategic leadership shift aimed at driving future growth.